AI Article Synopsis

  • The study focuses on the role of T regulatory cells (Tregs) in managing immune responses during COVID-19, highlighting their importance in controlling inflammation and immune balance throughout infection and recovery.
  • Researchers analyzed Treg subpopulations in COVID-19 patients at various stages—acute infection, early recovery, and long-term convalescence—finding a significant decrease in Tregs during the acute phase, which correlated with increased inflammation and disease severity.
  • After recovery, Treg levels gradually improved but did not fully return to those of healthy individuals one year later, indicating persistent immune changes, particularly in the expression of purinergic markers like CD39 and CD73.

Article Abstract

COVID-19, caused by SARS-CoV-2, triggers a complex immune response, with T regulatory cells (Tregs) playing a crucial role in maintaining immune homeostasis and preventing excessive inflammation. The current study investigates the function of T regulatory cells during COVID-19 infection and the subsequent recovery period, emphasizing their impact on immune regulation and inflammation control. We conducted a comprehensive analysis of Treg subpopulations in peripheral blood samples from COVID-19 patients at different stages: acute infection, early convalescence, and long-term recovery. Flow cytometry was employed to quantify Tregs including "naïve", central memory (CM), effector memory (EM), and terminally differentiated CD45RA effector cells (TEMRA). Additionally, the functional state of the Tregs was assessed by the expression of purinergic signaling molecules (CD39, CD73). Cytokine profiles were assessed through multiplex analysis. Our findings indicate a significant decrease in the number of Tregs during the acute phase of COVID-19, which correlates with heightened inflammatory markers and increased disease severity. Specifically, we found a decrease in the relative numbers of "naïve" and an increase in EM Tregs, as well as a decrease in the absolute numbers of "naïve" and CM Tregs. During the early convalescent period, the absolute counts of all Treg populations tended to increase, accompanied by a reduction in pro-inflammatory cytokines. Despite this, one year after recovery, the decreased subpopulations of regulatory T cells had not yet reached the levels observed in healthy donors. Finally, we observed the re-establishment of CD39 expression in all Treg subsets; however, there was no change in CD73 expression among Tregs. Understanding these immunological changes across different T regulatory subsets and adenosine signaling pathways offers important insights into the disease's pathogenesis and provides a broader view of immune system dynamics during recovery.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11545974PMC
http://dx.doi.org/10.3390/ijms252111759DOI Listing

Publication Analysis

Top Keywords

regulatory cells
12
numbers "naïve"
8
tregs
7
regulatory
5
covid-19
5
regulatory cell
4
cell subsets
4
subsets restore
4
restore year
4
year acute
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!